Camilleri Michael
Clinical Enteric Neuroscience Translational and Epidemiological Research Group, Mayo Clinic College of Medicine, Charlton 8-110, 200 First Street, SW, Rochester, MN 55905, USA.
Gastroenterol Clin North Am. 2007 Sep;36(3):649-64, xi-x. doi: 10.1016/j.gtc.2007.07.001.
With the exception of predominant heartburn, the management of upper abdominal symptoms not caused by an organic disorder remains a challenge. Systematic reviews of large trials show that suppressing acid secretion and eradicating Helicobacter pylori, prokinetics, and antidepressants have inconsistent effects on the treatment of functional dyspepsia. This inconsistent therapeutic efficacy has been attributed to the heterogeneity of patients, and the contribution of multiple mechanisms to development of symptoms. To achieve greater therapeutic efficacy, it may be necessary to target the therapeutic approach to a specific pathophysiology, such as impaired gastric emptying.
除了以烧心为主的症状外,对于非器质性疾病引起的上腹部症状的管理仍然是一项挑战。对大型试验的系统评价表明,抑制胃酸分泌、根除幽门螺杆菌、促动力药和抗抑郁药在功能性消化不良的治疗中效果不一。这种治疗效果的不一致归因于患者的异质性以及多种机制对症状发生的作用。为了获得更高的治疗效果,可能有必要针对特定的病理生理学,如胃排空受损,采取相应的治疗方法。